drugset / Trial / NCT02193698
Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial
NaSingle-groupOpen-labelTreatment
Summary
This study investigates the efficacy and safety of Lenalidomide as a treatment for recurrent or refractory POEMS (Crow-Fukase) syndrome.
Timeline
- Start
- 2014-07
- Primary completion
- 2015-10
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lenalidomide | Other / unclassified | 25 mg | — |
| Background | Dexamethasone | Small molecule | 20 mg | — |